{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:52:44Z","timestamp":1790855564793,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T00:00:00Z","timestamp":1456444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T00:00:00Z","timestamp":1456444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"DOI":"10.1038\/emm.2015.120","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T08:03:38Z","timestamp":1456473818000},"page":"e211-e211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis"],"prefix":"10.1038","volume":"48","author":[{"given":"Yune-Jung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ah","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daehee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Soo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Uk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,26]]},"reference":[{"key":"BFemm2015120_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010; 69: 631\u2013637.","journal-title":"Ann Rheum Dis"},{"key":"BFemm2015120_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/ard.2007.069690","volume":"67","author":"G Wells","year":"2008","unstructured":"Wells G, Li T, Maxwell L, Maclean R, Tugwell P . Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis 2008; 67: 260\u2013265.","journal-title":"Ann Rheum Dis"},{"key":"BFemm2015120_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/bmj.2.5544.85","volume":"2","author":"LE B\u00f6ttiger","year":"1967","unstructured":"B\u00f6ttiger LE, Svedberg CA . Normal erythrocyte sedimentation rate and age. Br Med J 1967; 2: 85\u201387.","journal-title":"Br Med J"},{"key":"BFemm2015120_CR4","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/art.1780340819","volume":"34","author":"I Kushner","year":"1991","unstructured":"Kushner I . C-reactive protein in rheumatology. Arthritis Rheum 1991; 34: 1065\u20131068.","journal-title":"Arthritis Rheum"},{"key":"BFemm2015120_CR5","first-page":"S","volume":"32","author":"T Pincus","year":"2014","unstructured":"Pincus T, Braun J, Kavanaugh A, Smolen JS . Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care. Clin Exp Rheumatol 2014; 32: S\u20131.","journal-title":"Clin Exp Rheumatol"},{"key":"BFemm2015120_CR6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1136\/ard.2005.035691","volume":"64","author":"VP Nell","year":"2005","unstructured":"Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 2005; 64: 1731\u20131736.","journal-title":"Ann Rheum Dis"},{"key":"BFemm2015120_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00467-012-2184-y","volume":"28","author":"L Watson","year":"2013","unstructured":"Watson L, Beresford MW . Urine biomarkers in juvenile-onset SLE nephritis. Pediatr Nephrol 2013; 28: 363\u2013374.","journal-title":"Pediatr Nephrol"},{"key":"BFemm2015120_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/dmrr.1068","volume":"26","author":"A Matheson","year":"2010","unstructured":"Matheson A, Willcox MD, Flanagan J, Walsh BJ . Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev 2010; 26: 150\u2013171.","journal-title":"Diabetes Metab Res Rev"},{"key":"BFemm2015120_CR9","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.1021\/pr500467d","volume":"13","author":"MJ Kang","year":"2014","unstructured":"Kang MJ, Park YJ, You S, Yoo SA, Choi S, Kim DH et al. Urinary proteome profile predictive of disease activity in rheumatoid arthritis. J Proteome Res 2014; 13: 5206\u20135217.","journal-title":"J Proteome Res"},{"key":"BFemm2015120_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315\u2013324.","journal-title":"Arthritis Rheum"},{"key":"BFemm2015120_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44\u201348.","journal-title":"Arthritis Rheum"},{"key":"BFemm2015120_CR12","first-page":"261","volume":"27","author":"D van der Heijde","year":"2000","unstructured":"van der Heijde D . How to read radiographs according to the Sharp\/van der Heijde method. J Rheumatol 2000; 27: 261\u2013263.","journal-title":"J Rheumatol"},{"key":"BFemm2015120_CR13","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1136\/ard.2011.150813","volume":"70","author":"JT Giles","year":"2011","unstructured":"Giles JT, van der Heijde DM, Bathon JM . Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis. Ann Rheum Dis 2011; 70: 1562\u20131568.","journal-title":"Ann Rheum Dis"},{"key":"BFemm2015120_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2249.1993.tb05884.x","volume":"91","author":"G Horneff","year":"1993","unstructured":"Horneff G, Sack U, Kalden JR, Emmrich F, Burmester GR . Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis. Clin Exp Immunol 1993; 91: 207\u2013213.","journal-title":"Clin Exp Immunol"},{"key":"BFemm2015120_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s002960050041","volume":"17","author":"S Yu","year":"1998","unstructured":"Yu S, Nakashima N, Xu BH, Matsuda T, Izumihara A, Sunahara N et al. Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: in the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts. Rheumatol Int 1998; 17: 237\u2013243.","journal-title":"Rheumatol Int"},{"key":"BFemm2015120_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/ard.57.9.533","volume":"57","author":"T Mottonen","year":"1998","unstructured":"Mottonen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P . Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with \"sawtooth\" strategy. Ann Rheum Dis 1998; 57: 533\u2013539.","journal-title":"Ann Rheum Dis"},{"key":"BFemm2015120_CR17","doi-asserted-by":"publisher","first-page":"12s","DOI":"10.1016\/S0002-9343(97)90003-6","volume":"103","author":"F Wolfe","year":"1997","unstructured":"Wolfe F . The prognosis of rheumatoid arthritis: assessment of disease activity and disease severity in the clinic. Am J Med 1997; 103: 12s\u201318s.","journal-title":"Am J Med"},{"key":"BFemm2015120_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/ard.2003.019992","volume":"64","author":"E Lindqvist","year":"2005","unstructured":"Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T . Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005; 64: 196\u2013201.","journal-title":"Ann Rheum Dis"},{"key":"BFemm2015120_CR19","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N","volume":"43","author":"MJ Plant","year":"2000","unstructured":"Plant MJ, Williams AL, O'Sullivan MM, Lewis PA, Coles EC, Jessop JD . Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum 2000; 43: 1473\u20131477.","journal-title":"Arthritis Rheum"},{"key":"BFemm2015120_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"J Smolen","year":"2014","unstructured":"Smolen J, Landew\u00e9 R, Breedveld FC, Buch M, Burmester G, Dougados M et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014; 73: 492\u2013509.","journal-title":"Ann Rheum Dis"},{"key":"BFemm2015120_CR21","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1074\/mcp.R800001-MCP200","volume":"7","author":"S Decramer","year":"2008","unstructured":"Decramer S, Gonzalez de Peredo A, Breuil B, Mischak H, Monsarrat B, Bascands JL et al. Urine in clinical proteomics. Molecular & cellular proteomics. Mol Cell Proteomics 2008; 7: 1850\u20131862.","journal-title":"Mol Cell Proteomics"},{"key":"BFemm2015120_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1503\/cmaj.061590","volume":"177","author":"J Barratt","year":"2007","unstructured":"Barratt J, Topham P . Urine proteomics: the present and future of measuring urinary protein components in disease. CMAJ 2007; 177: 361\u2013368.","journal-title":"CMAJ"},{"key":"BFemm2015120_CR23","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS . Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356\u2013361.","journal-title":"Nature"},{"key":"BFemm2015120_CR24","doi-asserted-by":"publisher","first-page":"R796","DOI":"10.1186\/ar1740","volume":"7","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005; 7: R796\u2013R806.","journal-title":"Arthritis Res Ther"},{"key":"BFemm2015120_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003; 42: 244\u2013257.","journal-title":"Rheumatology (Oxford)"},{"key":"BFemm2015120_CR26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 2012; 64: 640\u2013647.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFemm2015120_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/AC.69.2.3017291","volume":"69","author":"D Puttevils","year":"2014","unstructured":"Puttevils D, De Vusser P, Geusens P, Dens J . Increased cardiovascular risk in patients with rheumatoid arthritis: an overview. Acta Cardiol 2014; 69: 111\u2013118.","journal-title":"Acta Cardiol"},{"key":"BFemm2015120_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s11926-013-0354-y","volume":"15","author":"SM Goodman","year":"2013","unstructured":"Goodman SM, Mackenzie CR . Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery. Curr Rheumatol Rep 2013; 15: 354.","journal-title":"Curr Rheumatol Rep"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/emm2015120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/emm2015120","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/emm2015120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:20:21Z","timestamp":1672820421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/emm2015120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,26]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2]]}},"alternative-id":["BFemm2015120"],"URL":"https:\/\/doi.org\/10.1038\/emm.2015.120","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,26]]},"assertion":[{"value":"11 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}